• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Iconbiogen

biogen

Page 3 of 4
Biogen Stock Alzheimer's Aducanumab
NewslettersBiogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet
By Sy MukherjeeDecember 2, 2019
Biogen Alzheimers Aducanumab
NewslettersLet’s Talk About Biogen’s Stunning Alzheimer’s Drug Reversal: Brainstorm Health
By Sy MukherjeeOctober 22, 2019
Landlord To The Biotechs
HealthBiogen Acquires Nightstar Therapeutics in $800 Million Gene Therapy Deal
By Don ReisingerMarch 4, 2019
Alzheimer's Biogen Eisai
HealthWhy the Latest Alzheimer’s Drug Study Has So Many People Confused
By Clifton LeafJuly 30, 2018
BioGen Alzheimers
HealthBiogen’s Stock Is Soaring Because of Its Experimental Alzheimer’s Drug — But Some Are Urging Caution
By Sy MukherjeeJuly 6, 2018
COLOMBIA-YARUMAL-ALZHEIMER
HealthAlzheimer’s Cases Are Expected to Double By 2060 and We’re Not Ready for It
By Sy MukherjeeDecember 7, 2017
BioGen Alzheimers
HealthWe’ve Had Terrible Luck Trying to Cure Alzheimer’s. But What If We Could Prevent It?
By Sy MukherjeeNovember 2, 2017
BioGen Alzheimers
HealthCould a New Immunotherapy Medical Approach Break the Alzheimer’s Drug Curse?
By Sy MukherjeeOctober 24, 2017
COLOMBIA-YARUMAL-ALZHEIMER
HealthGoldman Sachs Bet on Biogen’s Potential Landmark Alzheimer’s Drug Props Up Stock
By Sy MukherjeeAugust 16, 2017
TechDo You Really Want to Love Your Medicines?
By Adam LashinskyJune 19, 2017
Incoming Biogen CEO Michel Vounatsos
HealthHere’s Why Biogen Is Forking Over $1.25 Billion to a Small Danish Biotech
By Sy MukherjeeJanuary 17, 2017
Novo Nordisk Chief Executive Officer Lars Soerensen Interview
LeadershipThis Big Pharma Chief Was Just Named the World’s ‘Best-Performing’ CEO—Again
By Sy MukherjeeOctober 12, 2016
TechBiogen Drug Shows Early Promise against Alzheimer’s Disease
By David Z. MorrisSeptember 3, 2016
George Scangos, CEO of Biogen Inc. speaks during Reuters Health Summit in New York
HealthBiogen Shares Are Spiking On Rumors of a Mega-Deal With Its Rivals
By Sy MukherjeeAugust 2, 2016
HealthWhistleblower Claims Celgene Colluded With Charities to Drive Profits
By Sy MukherjeeAugust 1, 2016
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
AI
A man let ChatGPT sell his home. It beat every agent's estimate by $100K—and closed in 5 daysAn image of a popular article
By Fortune EditorsMarch 21, 2026
Success
Covid gave us hybrid work. The Iran War might give us a four-day week—and this time, experts say it could stickAn image of a popular article
By Fortune EditorsMarch 21, 2026
Real Estate
Gen Z can’t afford a house. Some parents are choosing to fund their down payments over their college fundsAn image of a popular article
By Fortune EditorsMarch 20, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.